Many natural proteins are currently being used to treat diabetes, anemia, hepatitis and cancer. Currently approved protein pharmaceuticals are now being modified to improve their effectiveness at treating disease.

Maxygen is a leader in the optimization and modification of protein pharmaceuticals. We have assembled a series of technologies that make it possible to improve specific properties of protein pharmaceuticals in ways that have not been possible using traditional biotechnology methods.

Maxygen has three protein pharmaceuticals advancing towards clinical development. In each program, our goal is to generate an improved protein pharmaceutical with superior performance over the existing marketed product.

Return to Products